GBS (GBS) Competitors $1.90 -0.08 (-4.04%) As of 06/12/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesInsider TradesSEC FilingsTrendsBuy This Stock GBS vs. SRTS, NSPR, INO, CTCX, CTSO, TELA, APYX, NVNO, ICCM, and MODDShould you be buying GBS stock or one of its competitors? The main competitors of GBS include Sensus Healthcare (SRTS), InspireMD (NSPR), Inovio Pharmaceuticals (INO), Carmell (CTCX), Cytosorbents (CTSO), TELA Bio (TELA), Apyx Medical (APYX), enVVeno Medical (NVNO), IceCure Medical (ICCM), and Modular Medical (MODD). These companies are all part of the "surgical & medical instruments" industry. GBS vs. Its Competitors Sensus Healthcare InspireMD Inovio Pharmaceuticals Carmell Cytosorbents TELA Bio Apyx Medical enVVeno Medical IceCure Medical Modular Medical Sensus Healthcare (NASDAQ:SRTS) and GBS (NYSE:GBS) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, risk, analyst recommendations, earnings, valuation, profitability, community ranking, media sentiment and dividends. Is SRTS or GBS more profitable? Sensus Healthcare has a net margin of 15.90% compared to GBS's net margin of 0.00%. Sensus Healthcare's return on equity of 12.60% beat GBS's return on equity.Company Net Margins Return on Equity Return on Assets Sensus Healthcare15.90% 12.60% 11.38% GBS N/A -85.64%-54.42% Do insiders & institutionals believe in SRTS or GBS? 25.3% of Sensus Healthcare shares are held by institutional investors. Comparatively, 2.8% of GBS shares are held by institutional investors. 8.9% of Sensus Healthcare shares are held by company insiders. Comparatively, 0.3% of GBS shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Which has more risk and volatility, SRTS or GBS? Sensus Healthcare has a beta of 1.32, indicating that its share price is 32% more volatile than the S&P 500. Comparatively, GBS has a beta of 1.32, indicating that its share price is 32% more volatile than the S&P 500. Does the MarketBeat Community prefer SRTS or GBS? Sensus Healthcare received 187 more outperform votes than GBS when rated by MarketBeat users. CompanyUnderperformOutperformSensus HealthcareOutperform Votes18768.50% Underperform Votes8631.50% GBSN/AN/A Do analysts rate SRTS or GBS? Sensus Healthcare currently has a consensus price target of $11.67, indicating a potential upside of 142.55%. Given Sensus Healthcare's stronger consensus rating and higher probable upside, analysts plainly believe Sensus Healthcare is more favorable than GBS.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sensus Healthcare 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 3.25GBS 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has better earnings and valuation, SRTS or GBS? Sensus Healthcare has higher revenue and earnings than GBS. GBS is trading at a lower price-to-earnings ratio than Sensus Healthcare, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSensus Healthcare$39.49M2.00$6.65M$0.1048.10GBS$440K64.30-$8.31M-$0.56-3.39 Does the media refer more to SRTS or GBS? In the previous week, Sensus Healthcare had 6 more articles in the media than GBS. MarketBeat recorded 6 mentions for Sensus Healthcare and 0 mentions for GBS. Sensus Healthcare's average media sentiment score of 1.18 beat GBS's score of 0.41 indicating that Sensus Healthcare is being referred to more favorably in the media. Company Overall Sentiment Sensus Healthcare Positive GBS Neutral SummarySensus Healthcare beats GBS on 16 of the 17 factors compared between the two stocks. Get GBS News Delivered to You Automatically Sign up to receive the latest news and ratings for GBS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding GBS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GBS vs. The Competition Export to ExcelMetricGBSSurgical & medical instruments IndustryMedical SectorNYSE ExchangeMarket Cap$28.29M$4.32B$5.57B$19.66BDividend YieldN/A42.67%5.28%3.81%P/E Ratio-3.3927.8226.6335.03Price / Sales64.3068.18407.9942.85Price / CashN/A51.0838.2517.51Price / Book4.325.746.964.78Net Income-$8.31M$66.95M$3.23B$1.02B7 Day Performance14.46%-2.90%-1.05%0.81%1 Month Performance57.02%16.02%8.65%1.72%1 Year Performance-7.77%18.20%33.67%10.58% GBS Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GBSGBSN/A$1.90-4.0%N/A-15.2%$28.29M$440K-3.397SRTSSensus Healthcare2.4701 of 5 stars$4.83+2.3%$11.67+141.5%-10.6%$79.43M$39.49M12.0840Positive NewsAnalyst UpgradeNSPRInspireMD2.4859 of 5 stars$2.55+0.4%$4.50+76.5%-10.8%$78.12M$7.03M-3.4050News CoverageINOInovio Pharmaceuticals3.9889 of 5 stars$2.12+1.0%$9.75+359.9%-78.8%$77.75M$283.10K-0.66320Positive NewsAnalyst DowngradeCTCXCarmellN/A$3.27-0.9%N/A+32.0%$68.36M$32.84K0.0014News CoverageCTSOCytosorbents2.08 of 5 stars$1.00+16.6%$5.50+450.0%+26.0%$62.61M$35.33M-2.78220News CoverageTELATELA Bio2.4265 of 5 stars$1.57+10.6%$7.25+361.8%-69.3%$62.10M$71.22M-0.93120Analyst DowngradeAPYXApyx Medical2.3348 of 5 stars$1.62flatN/A+19.9%$61.23M$47.29M-1.95270News CoveragePositive NewsShort Interest ↓NVNOenVVeno Medical0.3745 of 5 stars$3.47-1.1%N/A-8.1%$60.85MN/A-2.6919Gap DownICCMIceCure Medical3.1914 of 5 stars$1.02-2.9%$2.50+145.1%+27.9%$56.61M$3.27M-3.5260Gap DownMODDModular Medical1.779 of 5 stars$0.88+11.1%N/A-54.7%$47.59MN/A-1.6620Upcoming EarningsGap Down Related Companies and Tools Related Companies Sensus Healthcare Alternatives InspireMD Alternatives Inovio Pharmaceuticals Alternatives Carmell Alternatives Cytosorbents Alternatives TELA Bio Alternatives Apyx Medical Alternatives enVVeno Medical Alternatives IceCure Medical Alternatives Modular Medical Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:GBS) was last updated on 6/14/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredGet in stocks now - and get out on this dateGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | Sponsored[First Look] Get in before potential 10X AI announcementsGo for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...Masters in Trading | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GBS Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share GBS With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy GBS Stock Free GBS Stock Alerts